| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.08 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.08 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |